Tenaya Therapeutics operates in the biotechnology sector focusing on heart disease treatments, facing competition from clinical-stage biopharmaceutical companies and gene-therapy developers working on cardiovascular therapies and genetic disorders. Comparable market peers and sector competitors include companies like 4D Molecular Therapeutics, Silence Therapeutics, and various specialized cardiovascular-focused genetic medicine firms developing innovative gene transfer and small-molecule drug candidates for failing heart conditions.